Espinosa, Sheryl M.
HRN: 22-81-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2023
CEFTRIAXONE 1G (VIAL)
03/29/2023
04/04/2023
IV
2g
OD
AGE; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes